The development and validation of a novel LC-MS/MS method for the simultaneous quantification of Molnupiravir and its metabolite ß-d-N4-hydroxycytidine in human plasma and saliva. (2021)
Attributed to:
AGILE: Seamless Phase I/IIa Platform for the Rapid Evaluation of Candidates for COVID-19 treatment
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.jpba.2021.114356
PubMed Identifier: 34509661
Publication URI: http://europepmc.org/abstract/MED/34509661
Type: Journal Article/Review
Volume: 206
Parent Publication: Journal of pharmaceutical and biomedical analysis
ISSN: 0731-7085